UPDATED Oct 03, 2025
Explore the Global Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
SPM | ₫10,800.00 | 0% | 0.9% | ₫148.7b | n/a | PE22.5x | n/a | 9.3% | ||
CAN | AU$0.014 | 0% | -79.7% | AU$9.3m | n/a | PE-0.4x | n/a | n/a | ||
8279 | NT$125.50 | 0% | -5.3% | NT$3.4b | n/a | PE12.2x | n/a | 4.0% | ||
4893 | JP¥168.00 | 0% | -12.0% | JP¥7.3b | JP¥440.00 | PS808.3x | E3.3% | n/a | ||
LPTI | US$0.0001 | 0% | n/a | US$2.3k | n/a | n/a | n/a | n/a | ||
RBII | US$0.000001 | 0% | 0% | US$1.1k | n/a | n/a | n/a | n/a | ||
A041910 | ₩6,880.00 | 0% | 1.2% | ₩91.4b | n/a | n/a | n/a | 1.5% | ||
A348080 | ₩953.00 | 0% | 7.2% | ₩70.4b | n/a | PS37.8x | n/a | n/a | ||
BST | €0.39 | 0% | 34.2% | €26.9m | n/a | PS9.1x | n/a | n/a | ||
2617 | HK$136.10 | 0% | n/a | HK$54.0b | n/a | PB84.9x | n/a | n/a | ||
4528 | JP¥1,697.00 | 0% | -15.6% | JP¥797.2b | JP¥1,612.50 | PE18.6x | E3.0% | 4.7% | ||
THCB.F | US$0.000001 | 0% | 0% | US$163.0 | n/a | n/a | n/a | n/a | ||
A291650 | ₩1,060.00 | 0% | -47.8% | ₩31.0b | n/a | n/a | n/a | n/a | ||
JUVA.F | US$0.000001 | 0% | -99.7% | US$164.0 | n/a | n/a | n/a | n/a | ||
SHWZ | US$0.000001 | 0% | -100.0% | US$85.0 | US$1.44 | PB0.000001x | n/a | n/a | ||
TCF | UK£0.0022 | 0% | -71.3% | UK£4.6m | n/a | PB0.8x | E-13.2% | n/a | ||
GENO | SEK 23.95 | 0% | -4.2% | SEK 1.6b | SEK 36.67 | PE58.7x | E34.9% | n/a | ||
BSFA | UK£0.03 | 0% | -25.0% | UK£3.9m | n/a | PS159.9x | n/a | n/a | ||
BXRX.Q | US$0.000001 | 0% | 0% | US$52.0 | n/a | n/a | n/a | n/a | ||
ALQGC | €0.072 | 0% | -5.0% | €5.0m | n/a | PS503305.9x | n/a | n/a | ||
OCGN | US$1.77 | 0% | 75.2% | US$552.8m | US$8.20 | PS116.3x | E73.5% | n/a | ||
MVMD | CA$0.015 | 0% | -57.1% | CA$5.3m | n/a | PS107.9x | n/a | n/a | ||
8V8 | €0.052 | 0% | 20.4% | €61.8m | n/a | PS1.9x | n/a | n/a | ||
FATE | US$1.21 | 0% | -62.4% | US$139.5m | US$4.45 | PS16.5x | E-4.4% | n/a |